Literature DB >> 8849729

A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.

I Dikic1, G Tokiwa, S Lev, S A Courtneidge, J Schlessinger.   

Abstract

The mechanisms by which mitogenic G-protein-coupled receptors activate the MAP kinase signalling pathway are poorly understood. Candidate protein tyrosine kinases that link G-protein-coupled receptors with MAP kinase include Src family kinases, the epidermal growth factor receptor, Lyn and Syk. Here we show that lysophosphatidic acid (LPA) and bradykinin induce tyrosine phosphorylation of Pyk2 and complex formation between Pyk2 and activated Src. Moreover, tyrosine phosphorylation of Pyk2 leads to binding of the SH2 domain of Src to tyrosine 402 of Pyk2 and activation of Src. Transient overexpression of a dominant interfering mutant of Pyk2 or the protein tyrosine kinase Csk reduces LPA- or bradykinin-induced activation of MAP kinase. LPA- or bradykinin-induced MAP kinase activation was also inhibited by overexpression of dominant interfering mutants of Grb2 and Sos. We propose that Pyk2 acts with Src to link Gi- and Gq-coupled receptors with Grb2 and Sos to activate the MAP kinase signalling pathway in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849729     DOI: 10.1038/383547a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  220 in total

1.  Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation.

Authors:  A Adomeit; A Graness; S Gross; K Seedorf; R Wetzker; C Liebmann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.

Authors:  A Takaoka; N Tanaka; Y Mitani; T Miyazaki; H Fujii; M Sato; P Kovarik; T Decker; J Schlessinger; T Taniguchi
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Identification of a new Pyk2 target protein with Arf-GAP activity.

Authors:  J Andreev; J P Simon; D D Sabatini; J Kam; G Plowman; P A Randazzo; J Schlessinger
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 4.  Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Authors:  Mariana M Belcheva; Carmine J Coscia
Journal:  Neurosignals       Date:  2002 Jan-Feb

Review 5.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

6.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

Review 7.  Cardioprotective signaling by endothelin.

Authors:  Anita Schorlemmer; Michelle L Matter; Ralph V Shohet
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

8.  Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.

Authors:  Wei Guo; Feng Wei; Shiping Zou; Meredith T Robbins; Shinichi Sugiyo; Tetsuya Ikeda; Jian-Cheng Tu; Paul F Worley; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 9.  Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction.

Authors:  J A Girault; G Labesse; J P Mornon; I Callebaut
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

10.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.